Neuland Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
NEULANDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Davuluri Rama Mohan Rao, a promoter of Neuland Laboratories Limited, has submitted a negative declaration confirming that neither he nor any other member of the Promoter and Promoter Group created any new share encumbrances (pledges) during the financial year 2025-26. This filing is a routine compliance requirement under SEBI regulations requiring promoters to disclose encumbrance activity periodically. The declaration states that no encumbrances were made beyond what was already previously disclosed.
This is a routine regulatory filing and the absence of new encumbrances is generally viewed as a positive signal by the market, indicating that promoter holdings remain unencumbered and reducing risk of forced share sales that could impact stock price.